These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37857647)

  • 1. Adaptive design of mRNA-loaded extracellular vesicles for targeted immunotherapy of cancer.
    Dong S; Liu X; Bi Y; Wang Y; Antony A; Lee D; Huntoon K; Jeong S; Ma Y; Li X; Deng W; Schrank BR; Grippin AJ; Ha J; Kang M; Chang M; Zhao Y; Sun R; Sun X; Yang J; Chen J; Tang SK; Lee LJ; Lee AS; Teng L; Wang S; Teng L; Kim BYS; Yang Z; Jiang W
    Nat Commun; 2023 Oct; 14(1):6610. PubMed ID: 37857647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functionalisation of extracellular vesicles with cyclic-RGDyC potentially for glioblastoma targeted intracellular drug delivery.
    Geng T; Leung E; Chamley LW; Wu Z
    Biomater Adv; 2023 Jun; 149():213388. PubMed ID: 37003022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of miR-9-5p, miR-124-3p, miR-21-5p, miR-138-5p, and miR-1-3p in Glioblastoma Cell Lines and Extracellular Vesicles.
    Zottel A; Šamec N; Kump A; Raspor Dall'Olio LR; Pužar Dominkuš P; Romih R; Hudoklin S; Mlakar J; Nikitin D; Sorokin M; Buzdin A; Jovčevska I; Komel R
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precise selection of aptamers targeting PD-L1 positive small extracellular vesicles on magnetic chips.
    Dong HY; Xie QH; Pang DW; Chen G; Zhang ZL
    Chem Commun (Camb); 2021 Apr; 57(29):3555-3558. PubMed ID: 33704314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small extracellular vesicles derived from PD-L1-modified mesenchymal stem cell promote Tregs differentiation and prolong allograft survival.
    Ou Q; Dou X; Tang J; Wu P; Pan D
    Cell Tissue Res; 2022 Sep; 389(3):465-481. PubMed ID: 35688948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photosensitive small extracellular vesicles regulate the immune microenvironment of triple negative breast cancer.
    Ding YN; Ding HY; Li H; Yang R; Huang JY; Chen H; Wang LH; Wang YJ; Hu CM; An YL; Zhang ZY; Yu WP; Tang QS; Shao GL
    Acta Biomater; 2023 Sep; 167():534-550. PubMed ID: 37302734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic engineering cellular vesicles expressing CD64 as checkpoint antibody carrier for cancer immunotherapy.
    Li L; Miao Q; Meng F; Li B; Xue T; Fang T; Zhang Z; Zhang J; Ye X; Kang Y; Zhang X; Chen Q; Liang X; Chen H; Zhang X
    Theranostics; 2021; 11(12):6033-6043. PubMed ID: 33897897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmenting Intracellular Cargo Delivery of Extracellular Vesicles in Hypoxic Tissues through Inhibiting Hypoxia-Induced Endocytic Recycling.
    Tong B; Liao Z; Liu H; Ke W; Lei C; Zhang W; Liang H; Wang H; He Y; Lei J; Yang K; Zhang X; Li G; Ma L; Song Y; Hua W; Feng X; Wang K; Wu X; Tan L; Gao Y; Yang C
    ACS Nano; 2023 Feb; 17(3):2537-2553. PubMed ID: 36730125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood-based PD-L1 analysis in tumor-derived extracellular vesicles: Applications for optimal use of anti-PD-1/PD-L1 axis inhibitors.
    Del Re M; van Schaik RHN; Fogli S; Mathijssen RHJ; Cucchiara F; Capuano A; Scavone C; Jenster GW; Danesi R
    Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188463. PubMed ID: 33137405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eliminating the original cargos of glioblastoma cell-derived small extracellular vesicles for efficient drug delivery to glioblastoma with improved biosafety.
    Guo Y; Hu G; Xia Y; Li H; Yuan J; Zhang J; Chen Y; Guo H; Yang Y; Wang Y; Deng Z
    Bioact Mater; 2022 Oct; 16():204-217. PubMed ID: 35386327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bio-clickable, small extracellular vesicles-COCKTAIL therapy for ischemic stroke.
    Haroon K; Ruan H; Zheng H; Wu S; Liu Z; Shi X; Tang Y; Yang GY; Zhang Z
    J Control Release; 2023 Nov; 363():585-596. PubMed ID: 37793483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Inflammation-Related Melanoma Small Extracellular Vesicle (sEV) mRNA Content Using Primary Melanocyte sEVs as a Reference.
    Bardi GT; Al-Rayan N; Richie JL; Yaddanapudi K; Hood JL
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30870978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reprogramming of T cell-derived small extracellular vesicles using IL2 surface engineering induces potent anti-cancer effects through miRNA delivery.
    Jung D; Shin S; Kang SM; Jung I; Ryu S; Noh S; Choi SJ; Jeong J; Lee BY; Kim KS; Kim CS; Yoon JH; Lee CH; Bucher F; Kim YN; Im SH; Song BJ; Yea K; Baek MC
    J Extracell Vesicles; 2022 Dec; 11(12):e12287. PubMed ID: 36447429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour tissue-derived small extracellular vesicles reflect molecular subtypes of bladder cancer.
    Dong L; Feng M; Kuczler MD; Horie K; Kim CJ; Ma Z; Lombardo K; Lyons H; Amend SR; Kates M; Bivalacqua TJ; McConkey D; Xue W; Choi W; Pienta KJ
    J Extracell Vesicles; 2024 Feb; 13(2):e12402. PubMed ID: 38293707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic potential of miR-21 regulation by human peripheral blood derived-small extracellular vesicles in myocardial infarction.
    Kang JY; Kim H; Mun D; Yun N; Joung B
    Clin Sci (Lond); 2020 Apr; 134(8):985-999. PubMed ID: 32297634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular vesicles and ctDNA in lung cancer: biomarker sources and therapeutic applications.
    Huang C; Liu S; Tong X; Fan H
    Cancer Chemother Pharmacol; 2018 Aug; 82(2):171-183. PubMed ID: 29948020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy of cancer with dendritic cells loaded with tumor antigens and activated through mRNA electroporation.
    Van Nuffel AM; Corthals J; Neyns B; Heirman C; Thielemans K; Bonehill A
    Methods Mol Biol; 2010; 629():405-52. PubMed ID: 20387165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineered Small Extracellular Vesicles as a FGL1/PD-L1 Dual-Targeting Delivery System for Alleviating Immune Rejection.
    Tsai HI; Wu Y; Liu X; Xu Z; Liu L; Wang C; Zhang H; Huang Y; Wang L; Zhang W; Su D; Khan FU; Zhu X; Yang R; Pang Y; Eriksson JE; Zhu H; Wang D; Jia B; Cheng F; Chen H
    Adv Sci (Weinh); 2022 Jan; 9(3):e2102634. PubMed ID: 34738731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local and Targeted Delivery of Immune Checkpoint Blockade Therapeutics.
    Han X; Li H; Zhou D; Chen Z; Gu Z
    Acc Chem Res; 2020 Nov; 53(11):2521-2533. PubMed ID: 33073988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular vesicle-based drug delivery in cancer immunotherapy.
    Najafi S; Majidpoor J; Mortezaee K
    Drug Deliv Transl Res; 2023 Nov; 13(11):2790-2806. PubMed ID: 37261603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.